Arizona Ketamine Treatment and Research Institute
www.arizonaketamine.comThere is new hope for sufferers of Depression and other Neuropsychiatric conditions – the medication Ketamine. Over 75% of patients with depression, including Treatment-Resistant Depression, experience rapid relief of symptoms after Ketamine therapy. The majority of patients with bipolar disorder, chronic anxiety, PTSD, OCD, panic disorder, or agoraphobia will also have significant relief or even complete resolution of symptoms after Ketamine infusions. With a short series of infusions, symptomatic relief can last for weeks or months – including immediate relief from anxiety, anhedonia (inability to experience joy), physical fatigue, dysphoria (melancholy), cognitive impairment, insomnia and more. When physical symptoms are relieved, patients experience a dramatic improvement in mood.
Read moreReach decision makers at Arizona Ketamine Treatment and Research Institute
Free credit every month!
There is new hope for sufferers of Depression and other Neuropsychiatric conditions – the medication Ketamine. Over 75% of patients with depression, including Treatment-Resistant Depression, experience rapid relief of symptoms after Ketamine therapy. The majority of patients with bipolar disorder, chronic anxiety, PTSD, OCD, panic disorder, or agoraphobia will also have significant relief or even complete resolution of symptoms after Ketamine infusions. With a short series of infusions, symptomatic relief can last for weeks or months – including immediate relief from anxiety, anhedonia (inability to experience joy), physical fatigue, dysphoria (melancholy), cognitive impairment, insomnia and more. When physical symptoms are relieved, patients experience a dramatic improvement in mood.
Read moreCountry
State
Arizona
City (Headquarters)
Tempe
Industry
Employees
11-50
Founded
2016
Social
Employees statistics
View all employeesPotential Decision Makers
Research Assistant Ii / Project Coordinator
Email ****** @****.comPhone (***) ****-****